Athira Pharma Inc.

13F holders, Q1 2025 (March 31)
54holders −2
2new positions
3sold out
2famous investors
$0.28avg. 13F price*

At the end of Q1 2025, 54 institutions reported holding Athira Pharma Inc. in their 13F filings, down 2 from Q4 2024. 2 opened new positions and 3 sold out. The largest holders were Perceptive Advisors LLC ($1.5M), BML Capital Management, LLC ($912K) and Vanguard Group Inc. ($438K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Athira Pharma Inc.
CUSIP
04746L104
Latest filing quarter
Q3 2025

History

Number of 13F holders

020406080 Q1 2024: 75Q1 2024Q2 2024: 65Q2 2024Q3 2024: 58Q3 2024Q4 2024: 56Q4 2024Q1 2025: 54Q1 2025Q2 2025: 51Q2 2025Q3 2025: 2Q3 2025

Total Exit/New Position Q4 2024 → Q1 2025

InstitutionsTotal Value
New Positions2$15K
Exits3$21K

All 13F filers, Q4 2024 → Q1 2025: 544,146 shares bought and 901,926 shares sold, net −357,780 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 54 holders

Perceptive Advisors LLC 0.05% No change 5,402,964 $1.5M
BML Capital Management, LLC 0.74% Add +15.3% 3,200,667 $912K
Vanguard Group Inc. 0.00% Reduce -1.2% 1,537,914 $438K
Propel Bio Management, LLC 0.49% No change 1,492,792 $425K
Simplify Asset Management Inc. 0.02% No change 1,492,792 $425K
Tang Capital Management LLC 0.01% No change 600,000 $171K
BlackRock, Inc. 0.00% Reduce -0.3% 457,199 $130K
Acadian Asset Management LLC 0.00% Reduce -1.4% 428,533 $121K
Bank of America Corp. 0.00% Add +0.0% 416,158 $118K
Pathstone Holdings, LLC 0.00% No change 372,196 $106K
Geode Capital Management, LLC 0.00% Reduce -2.9% 311,498 $89K
Bristlecone Advisors, LLC 0.01% Reduce -25.3% 252,200 $72K
Qube Research & Technologies Ltd 0.00% Reduce -36.8% 221,068 $63K
Renaissance Technologies 0.00% Add +5.6% 219,000 $62K
Two Sigma Advisers, LP 0.00% Reduce -38.0% 157,100 $45K
Laird Norton Wetherby Trust Company, LLC 0.01% No change 127,309 $36K
State Street Corp. 0.00% No change 107,381 $31K
Gsa Capital Partners LLP 0.00% Reduce -70.3% 88,233 $25K
UBS Group AG 0.00% Reduce -12.0% 76,551 $22K
Northern Trust Corp. 0.00% No change 53,609 $15K
Clarius Group, LLC 0.00% No change 53,551 $15K
Integrity Financial Corp 0.01% Add +61.4% 52,902 $15K
Citadel Advisors 0.00% New 49,573 $14K
XTX Topco Ltd 0.00% Add +160.9% 46,148 $13K
Invst, LLC 0.00% No change 45,000 $13K
Easterly Investment Partners LLC 0.00% No change 33,500 $10K
Brighton Jones LLC 0.00% No change 32,200 $9K
Osaic Holdings, Inc. 0.00% Reduce -56.7% 27,500 $8K
Simon Quick Advisors, LLC 0.00% No change 20,538 $6K
Journey Strategic Wealth LLC 0.00% No change 20,538 $6K
Blair William & Co. 0.00% No change 20,000 $6K
Susquehanna International Group, LLP 0.00% Reduce -62.0% 18,753 $5K
Shay Capital LLC 0.00% Add +57.5% 18,586 $5K
Vanguard Personalized Indexing Management, LLC 0.00% Reduce -63.7% 14,165 $4K
Royal Bank of Canada 0.00% Reduce -92.3% 14,154 $4K
HRT Financial LP 0.00% Reduce -67.1% 14,077 $4K
HighTower Advisors, LLC 0.00% No change 12,697 $4K
Engineers Gate Manager LP 0.00% Reduce -32.9% 11,042 $3K
Prelude Capital Management, LLC 0.00% No change 11,000 $3K
Tower Research Capital LLC (TRC) 0.00% Reduce -28.7% 9,547 $3K
Lindbrook Capital, LLC 0.00% No change 8,920 $3K
Morgan Stanley 0.00% Reduce -15.0% 5,112 $1K
Coldstream Capital Management Inc. 0.00% New 2,640 $753
American Capital Advisory, LLC 0.00% No change 2,000 $570
Rothschild Investment LLC 0.00% No change 1,500 $427
BNP Paribas Financial Markets 0.00% No change 1,361 $388
Federated Hermes, Inc. 0.00% Reduce -18.1% 831 $237
McIlrath & Eck, LLC 0.00% No change 825 $235
US Bancorp \de 0.00% No change 815 $232
Jones Financial Companies LLLP 0.00% No change 334 $102
SBI Securities Co., Ltd. 0.00% Add +48.0% 228 $65
JPMorgan Chase & Co. 0.00% No change 143 $41
Barclays PLC 0.00% Reduce -89.5% 4 $1
Simplex Trading, LLC 0.00% Reduce -85.2% 324 $0

"% of holder's portfolio" is ATHIRA PHARMA INC's weight in each manager's 13F, not the share of Athira Pharma Inc. the manager owns.